Abstract:Background & AimsLiver biopsy is the reference standard for staging and grading non-alcoholic fatty liver disease (NAFLD), but histologic scoring systems are semi-quantitative with marked inter- and intra-observer variation. We used machine learning to develop fully automated software for quantification of steatosis, inflammation, ballooning, and fibrosis in biopsies from patients with NAFLD and validated the technology in a separate group of patients.MethodsWe collected data from 246 consecutive patients with biopsy-proven NAFLD and followed in London, the United Kingdom, from January 2010 through December 2016. Biopsies from the first 100 patients were used to derive the algorithm and biopsies from the following 146 were used to validate it. Biopsies were independently scored by pathologists using the nonalcoholic steatohepatitis clinical research network criteria and digitalized. Areas of steatosis, inflammation, ballooning, and fibrosis were annotated on biopsies by 2 hepatobiliary histopathologists to facilitate machine learning. Images of biopsies from the derivation and validation sets were then analyzed by the algorithm to compute percentages of fat, inflammation, ballooning, and fibrosis, as well as collagen proportionate area (CPA), and compared with findings from pathologists' manual annotations and conventional scoring systems.ResultsIn the derivation group, results from manual annotation and the software had an inter-class correlation coefficient (ICC) of 0.97 for steatosis (95%CI, 0.95–0.99; P<.001); ICC, 0.96 for inflammation (95%CI, 0.9–0.98; P<.001); ICC, 0.94 for ballooning (95%CI, 0.87–0.98; P<.001); and ICC, 0.92 for fibrosis (95%CI, 0.88–0.96; P=.001). Percentages of fat, inflammation, ballooning, and CPA from the derivation group were confirmed in the validation cohort. The software identified histological features of NAFLD with levels of inter- and intra-observer agreement ranging from 0.95 to 0.99; this value was higher than that of semi-quantitative scoring systems which ranged 0.58 to 0.88. In a subgroup of paired liver biopsies, quantitative analysis was more sensitive in detecting differences compared to the nonalcoholic steatohepatitis Clinical Research Network scoring system.ConclusionsWe used machine learning to develop software to rapidly and objectively analyse liver biopsies for histologic features of NAFLD. The results from the software correlate with those from histopathologists, with high levels of inter- and intra-observer agreement. Findings were validated in a separate group of patients. This tool might be used for objective assessment of response to therapy for NAFLD in practice and clinical trials.

Deep learning for noninvasive liver fibrosis classification: A systematic review

Classification of Focal Liver Lesions Using Deep Learning with Fine-Tuning

Deep Learning Radiomics for Focal Liver Lesions Diagnosis on Long-Range Contrast-Enhanced Ultrasound and Clinical Factors

Deep learning for staging liver fibrosis on CT: a pilot study

Deep Learning for Accurate Diagnosis of Liver Tumor Based on Magnetic Resonance Imaging and Clinical Data

Deep Learning-Assisted Diagnosis of Liver Tumors Using Non-Contrast Magnetic Resonance Imaging: A Multi-Center Study

Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent–enhanced CT Images in the Liver

Deep learning for image-based liver analysis - A comprehensive review focusing on malignant lesions

Deep Learning–Based Approach for Identifying and Measuring Focal Liver Lesions on Contrast‐Enhanced MRI

Quantitative Evaluation of Liver Fibrosis Based on Ultrasound Radio Frequency Signals: an Animal Experimental Study

Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future

[Computer-Aided Assessment of Liver Fibrosis Progression in Patients with Chronic Hepatitis B: an Exploratory Research].

Optical Insights into Fibrotic Livers: Applications of Near-Infrared Spectroscopy and Machine Learning

Ultrasonic Assessment of Liver Fibrosis Using One-Dimensional Convolutional Neural Networks Based on Frequency Spectra of Radiofrequency Signals with Deep Learning Segmentation of Liver Regions in B-Mode Images: A Feasibility Study

Application of artificial intelligence in chronic liver diseases: a systematic review and meta-analysis

AutoFibroNet: A deep learning and multi‐photon microscopy‐derived automated network for liver fibrosis quantification in MAFLD

Recent advances in molecular magnetic resonance imaging of liver fibrosis.

High-Throughput, Machine Learning–Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease

Deep Learning With Ultrasound Images Enhance the Diagnosis of Nonalcoholic Fatty Liver

Point‐of‐care detection of fibrosis in liver transplant surgery using near‐infrared spectroscopy and machine learning

Deep learning for assessing liver fibrosis based on acoustic nonlinearity maps: an in vivo study of rabbits